drugset / Trial / NCT00296179

Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro

NCT00296179 ↗

Phase 4 Completed 372 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

To demonstrate overall improvement of insomnia in subjects treated with zolpidem tartrate extended-release (Ambien CR) and escitalopram (Lexapro) vs. subjects treated with placebo and escitalopram at 2 months.

Timeline

Start
2006-02
Primary completion
2007-06
Completion
—

Outcome

Met primary endpoint

paper Throughout phase 1, zolpidem extended-release led to significantly greater improvements in total sleep time (P < .0001) PMID 21208597 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule — —

Indications